Perceptive Advisors LLC Zymeworks Inc. Transaction History

Perceptive Advisors LLC

$3.83 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$4.65 - $7.43 $1.24 Million - $1.99 Million	267,565 Added 6.47%	4,400,099 $27.1 Million
Q2 2022 Aug 15, 2022	SELL	$4.82 - $7.7 $5.75 Million - $9.19 Million	-1,193,081 Reduced 22.4%	4,132,534 $21.9 Million
Q1 2022 May 16, 2022	BUY	$6.0 - $16.98 $9.87 Million - $27.9 Million	1,645,770 Added 44.72%	5,325,615 $34.9 Million
Q3 2021 Nov 15, 2021	SELL	$27.35 - $37.28 $17.1 Million - $23.3 Million	-625,755 Reduced 14.53%	3,679,845 $107 Million
Q2 2021 Aug 16, 2021	SELL	$26.5 - $38.23 $669,602 - $965,995	-25,268 Reduced 0.58%	4,305,600 $149 Million
Q1 2021 May 17, 2021	BUY	$29.83 - $56.81 $890,992 - $1.7 Million	29,869 Added 0.69%	4,330,868 $137 Million
Q4 2020 Feb 16, 2021	SELL	$39.12 - $54.99 $3.91 Million - $5.5 Million	-100,000 Reduced 2.27%	4,300,999 $203 Million
Q3 2020 Nov 16, 2020	BUY	$29.21 - $46.58 $24 Million - $38.2 Million	820,000 Added 22.9%	4,400,999 $205 Million
Q2 2020 Aug 14, 2020	BUY	$33.67 - $40.0 $673,400 - $800,000	20,000 Added 0.56%	3,580,999 $129 Million
Q1 2020 May 15, 2020	BUY	$24.28 - $49.8 $28.1 Million - $57.7 Million	1,157,973 Added 48.19%	3,560,999 $126 Million
Q4 2019 Feb 14, 2020	BUY	$24.84 - $45.46 $351,138 - $642,622	14,136 Added 0.59%	2,403,026 $109 Million
Q3 2019 Nov 14, 2019	BUY	$22.78 - $29.08 $455,600 - $581,600	20,000 Added 0.84%	2,388,890 $59.2 Million
Q2 2019 Aug 14, 2019	BUY	$15.0 - $22.49 $26.9 Million - $40.4 Million	1,795,000 Added 312.78%	2,368,890 $52.1 Million
Q4 2018 Feb 14, 2019	SELL	$10.95 - $15.44 $6.02 Million - $8.49 Million	-550,000 Reduced 48.94%	573,890 $7.2 Million
Q2 2018 Aug 14, 2018	BUY	$11.13 - $21.86 $4.79 Million - $9.4 Million	430,000 Added 61.97%	1,123,890 $15.9 Million
Q1 2018 May 15, 2018	SELL	$7.93 - $13.41 $663,003 - $1.12 Million	-83,607 Reduced 10.75%	693,890 $7.78 Million
Q4 2017 Feb 14, 2018	BUY	$6.87 - $9.19 $321,028 - $429,439	46,729 Added 6.39%	777,497 $5.55 Million
Q3 2017 Nov 14, 2017	BUY	$6.48 - $8.73 $4.74 Million - $6.38 Million	730,768	730,768 $5.83 Million

Others Institutions Holding ZYME

# of Institutions

Shares Held

296K

Call Options Held

Put Options Held

Strategic Wealth Advisors Group, LLC Sacramento, CA

296K
Shares

$4.34 Million
0.08% of portfolio

View Full List

About Zymeworks Inc.

Ticker ZYME
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,694,400
Market Cap $903M
Description
Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas...

More about ZYME

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Perceptive Advisors LLC with notifications on news.

Account